Sintx Technologies (SXTP) Reports Latest Pharmaceutical Developments in Infectious Disease Research
60 Degrees Pharmaceuticals (NASDAQ: SXTP) recently released its fiscal results for the first quarter of 2026, highlighting ongoing efforts to advance therapeutic interventions for infectious diseases. The company continues to ... Read More